Old Web
English
Sign In
Acemap
>
Paper
>
CLINICAL TRIAL DESIGN FOR A PHASE II, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF AMX0035 IN ALZHEIMER’S DISEASE
CLINICAL TRIAL DESIGN FOR A PHASE II, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF AMX0035 IN ALZHEIMER’S DISEASE
2018
Kent L. Leslie
Joshua T. Cohen
Justin Klee
Victoria J. Williams
Steven E. Arnold
Keywords:
Clinical study design
Psychiatry
Disease
Placebo-controlled study
Psychology
Physical therapy
Internal medicine
Diabetes mellitus
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]